FILE:TMO/TMO-8K-20080528143756.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
Table of Contents
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
 
 
Table of Contents
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Election of Director
     On May 27, 2008, by vote of the Board of Directors of Thermo Fisher Scientific Inc. (the "Company"), Judy C. Lewent was elected a director of the Company. Ms. Lewent was appointed to the Strategy Review Committee.
     Ms. Lewent was formerly executive vice president and chief financial officer of Merck & Co., Inc., where she was employed from 1980 to 2007. She also served as president, Human Health Asia at Merck.
Table of Contents
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, on this 28th day of May, 2008.


